SCHEMBL8438993

SCHEMBL8438993

Cc1cc(NC(=O)C(O)c2ccc3c(c2)C(C)(C)CCC3(C)C)ccc1S(=O)(=O)c1ccc(NC(=O)C(O)c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 11/20 0.51
RARB P10826 7/20 0.51
RARG P13631 7/20 0.51
CYP3A4 P08684 4/20 0.51
RXRA P19793 3/20 0.43
RARA P10276 6/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PGR P06401 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
TBXA2R P21731 1/20 0.42
BLVRB P30043 1/20 0.42
RXRB P28702 2/20 0.41
RXRG P48443 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8604289 0.81 CYP26A1 (0.53) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL5080286 0.78 RARB (0.71) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL8839114 0.77 RARG (0.57) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL8839311 0.75 RARG (0.50) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL10336597 0.72 RARB (0.62) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL8839136 0.70 RARB (0.52) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL9350200 0.70 RXRA (0.64) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL7871498 0.70 RXRA (0.64) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL8103042 0.70 RARB (0.47) CYP26A1RARBRARGCYP3A4RXRA
SCHEMBL8106316 0.69 CYP26A1 (0.44) CYP26A1RARBRARGCYP3A4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6001885-A INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION IN KERATINOCYTES BY ADMINISTERING AT LEAST ONE RETINOID; USEFUL FOR TREATING DISEASES RELATING TO VEGF OVEREXPRESSION, SUCH AS PSORIASIS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 1999-12-14 US claimed
US-6001885-A INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION IN KERATINOCYTES BY ADMINISTERING AT LEAST ONE RETINOID; USEFUL FOR TREATING DISEASES RELATING TO VEGF OVEREXPRESSION, SUCH AS PSORIASIS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 1999-12-14 US disclosed